| Formulation |
The PTMA solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl and 10% glycerol. |
| Purity |
Greater than 95.0% as determined by SDS-PAGE. |
| Description |
PTMA Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 133 amino acids (1-110) and having a molecular mass of 14.5 kDa.PTMA is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
| Protein Background |
Prothymosin alpha (PTMA) is a part of the pro/parathymosin family. PTMA mediates immune function by conferring resistance to some opportunistic infections. |
| Expression host |
Escherichia Coli. |
| Synonyms |
Prothymosin alpha, TMSA, PTMA, Prothymosin alpha, N-terminally processed, Thymosin alpha-1. |
| Reagent Appearance |
Sterile Filtered colorless solution. |
| Stability |
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. |
| Amino acid sequence |
MGSSHHHHHH SSGLVPRGSH MGSMSDAAVD TSSEITTKDL KEKKEVVEEA ENGRDAPANG NANEENGEQE ADNEVDEEEE EGGEEEEEEE EGDGEEEDGD EDEEAESATG KRAAEDDEDD DVDTKKQKTD EDD. |
| 5 Unit Definition |
Immunoreactive with sera of Rubella Virus infected individuals. |
